PAULA'S CHOICE CLEAR ANTI-ACNE EXTRA STRENGTH SYSTEM 2 %
SALICYLIC ACID : 2 % BENZOYL PEROXIDE : 5 % · DIN 02436477 · PAULA'S CHOICE LLC
Health Canada status: CANCELLED PRE MARKET
What is PAULA'S CHOICE CLEAR ANTI-ACNE EXTRA STRENGTH SYSTEM?
PAULA'S CHOICE CLEAR ANTI-ACNE EXTRA STRENGTH SYSTEM 2 % contains SALICYLIC ACID : 2 % BENZOYL PEROXIDE : 5 %. It is listed in the Health Canada Drug Product Database under DIN 02436477, held by PAULA'S CHOICE LLC, supplied as LOTION ; SOLUTION ; KIT for TOPICAL administration. Health Canada currently lists it as cancelled pre market, status dated 18-Apr-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02436477 |
|---|---|
| Brand name | PAULA'S CHOICE CLEAR ANTI-ACNE EXTRA STRENGTH SYSTEM |
| Generic / active ingredient | SALICYLIC ACID : 2 % BENZOYL PEROXIDE : 5 % |
| Manufacturer | PAULA'S CHOICE LLC |
| Strength | 2 % |
| Dosage form | LOTION ; SOLUTION ; KIT |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D10AE51 BENZOYL PEROXIDE, COMBINATIONS |
| AHFS class | 84:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 18-Apr-2017 |
What can be used instead?
Other Canadian products sharing ATC code D10AE51 BENZOYL PEROXIDE, COMBINATIONS. 1 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACNE TREATMENT SYSTEM | 2 % | LIQUID ; LOTION ; KIT | VIVIER CANADA INCORPORATED | MARKETED | DIN 02402149 |
| COMPLETE ACNE THERAPY SYSTEM | 2.5 % | GEL ; KIT ; LOTION | JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02453436 |
| PANOXYL 15 ACNE GEL | 15 % | GEL | STIEFEL CANADA ULC | CANCELLED POST MARKET | DIN 00403571 |
| PAULA'S CHOICE CLEAR ANTI-ACNE REGULAR STRENGTH SYSTEM | 2.5 % | LOTION ; SOLUTION ; KIT | PAULA'S CHOICE LLC | CANCELLED PRE MARKET | DIN 02436469 |
| R+F PAIRED REGIMEN FOR WRINKLES + OCCASIONAL ACNE | 3.4 % | GEL ; KIT ; LOTION | RODAN & FIELDS BEAUTY, LLC | APPROVED | DIN 02546868 |
Who else supplies BENZOYL PEROXIDE, COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BENZOYL PEROXIDE, COMBINATIONS appears in 24 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for PAULA'S CHOICE CLEAR ANTI-ACNE EXTRA STRENGTH SYSTEM
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.